all i got was ....
2.
Does TLX consider the Information to be information that a reasonable person would expect to have a material effect on the price or value of its securities?
Yes. TLX592 is an antibody-based targeted alpha-therapy for prostate cancer and is a key part of the Company’s prostate cancer pipeline. The Company considers the Information to be material as it relates to an important inflection point in the development program for TLX592.
Ann: Response to ASX Query, page-3
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.83 |
Change
-0.670(3.62%) |
Mkt cap ! $6.007B | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.40 | $17.78 | $8.411M | 467.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2617 | $17.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.83 | 537 | 9 |
View Market Depth
| Last trade - 15.18pm 18/09/2024 (20 minute delay) ? |
| TLX (ASX) Chart |